Cohen, M., et al. (2012) Neurological Adverse Events Under Anti-TNF Alpha Therapy. Revue Neurologique, 168, 33-39.
https://doi.org/10.1016/j.neurol.2011.06.005

has been cited by the following article:

• TITLE: Peripheral Neuropathy under Infliximab Therapy: About One Case

  AUTHORS: Fatima-Zahra Hamdoun, Hakima Abid, Nada Lahmidani, Mounia El Yousfi, Dafr-Allah Benajah, Mohammed El Abkari, Adil Ibrahimi

  KEYWORDS: Crohn’s Disease, Infliximab, Peripheral Neuropathy

  JOURNAL NAME: Open Journal of Gastroenterology, Vol.10 No.9, September 27, 2020

  ABSTRACT: A-TNF inhibitors are increasingly used in various inflammatory disorders. Multiple side effects have been reported in recent years, particularly peripheral neuropathies. We report a case of axonal neuropathy occurring after the start of treatment with Infliximab. This is a 47 years old patient, followed for Crohn’s disease requiring treatment with Infliximab. Twenty-two weeks later, the patient presented a grade 4 of axonal neuropathy. We concluded to a medicinal sensitive neuropathy after elimination of other etiologies. Given the severity of the neurological symptoms, we decided to change the therapeutic class.